ACADIA Pharmaceuticals Inc (ACAD) — Working Capital to Net Assets Ratio
ACADIA Pharmaceuticals Inc (ACAD) has a Working Capital to Net Assets ratio of 63.3% as of March 2026. Working capital of $790.49 Million (current assets of $1.10 Billion minus current liabilities of $305.52 Million) is measured against net assets of $1.25 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See ACADIA Pharmaceuticals Inc (ACAD) flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
ACADIA Pharmaceuticals Inc Working Capital to Net Assets (2002–2025)
This chart shows how ACADIA Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2002 to 2025. As of March 2026, the ratio stands at 63.3%, reflecting working capital of $790.49 Million against net assets of $1.25 Billion USD. See operational self-sufficiency of ACADIA Pharmaceuticals Inc to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for ACADIA Pharmaceuticals Inc (2002–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for ACADIA Pharmaceuticals Inc from 2002 to 2025, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see ACAD market cap overview.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 64.0% | $785.00 Million | $1.23 Billion | $1.06 Billion | $277.11 Million | ▼ -10.2 pp |
| 2024 | 74.2% | $543.45 Million | $732.79 Million | $938.32 Million | $394.87 Million | ▼ -9.7 pp |
| 2023 | 83.8% | $361.87 Million | $431.75 Million | $616.12 Million | $254.25 Million | ▼ -11.7 pp |
| 2022 | 95.5% | $382.31 Million | $400.41 Million | $507.94 Million | $125.63 Million | ▼ -1.0 pp |
| 2021 | 96.5% | $521.75 Million | $540.89 Million | $617.82 Million | $96.07 Million | ▼ -1.1 pp |
| 2020 | 97.6% | $611.65 Million | $627.01 Million | $717.62 Million | $105.97 Million | ▼ -0.5 pp |
| 2019 | 98.0% | $685.42 Million | $699.13 Million | $760.25 Million | $74.83 Million | ▲ +0.7 pp |
| 2018 | 97.4% | $466.54 Million | $479.08 Million | $526.11 Million | $59.56 Million | ▲ +0.6 pp |
| 2017 | 96.8% | $324.45 Million | $335.29 Million | $373.48 Million | $49.03 Million | ▼ -0.7 pp |
| 2016 | 97.5% | $505.31 Million | $518.41 Million | $547.90 Million | $42.59 Million | ▼ -1.2 pp |
| 2015 | 98.7% | $197.09 Million | $199.76 Million | $218.99 Million | $21.90 Million | ▼ -1.1 pp |
| 2014 | 99.8% | $308.78 Million | $309.49 Million | $324.62 Million | $15.83 Million | ▲ +0.2 pp |
| 2013 | 99.6% | $181.38 Million | $182.13 Million | $188.36 Million | $6.98 Million | ▼ -21.1 pp |
| 2012 | 120.7% | $102.60 Million | $84.98 Million | $108.55 Million | $5.95 Million | ▲ +10.4 pp |
| 2011 | 110.4% | $25.78 Million | $23.36 Million | $31.95 Million | $6.17 Million | ▲ +3.0 pp |
| 2010 | 107.4% | $31.89 Million | $29.69 Million | $37.85 Million | $5.96 Million | ▼ -171.3 pp |
| 2009 | 278.7% | $33.77 Million | $12.11 Million | $48.47 Million | $14.71 Million | ▲ +181.9 pp |
| 2008 | 96.9% | $51.33 Million | $52.99 Million | $62.38 Million | $11.05 Million | ▼ -1.4 pp |
| 2007 | 98.3% | $111.97 Million | $113.93 Million | $131.25 Million | $19.29 Million | ▲ +1.1 pp |
| 2006 | 97.2% | $65.25 Million | $67.16 Million | $85.78 Million | $20.53 Million | ▼ -0.4 pp |
| 2005 | 97.6% | $38.42 Million | $39.37 Million | $60.12 Million | $21.70 Million | ▲ +2.5 pp |
| 2004 | 95.1% | $29.18 Million | $30.68 Million | $37.82 Million | $8.64 Million | ▲ +133.2 pp |
| 2003 | -38.1% | $20.05 Million | $-52.67 Million | $28.27 Million | $8.23 Million | ▼ -20.4 pp |
| 2002 | -17.7% | $7.10 Million | $-40.09 Million | $13.25 Million | $6.15 Million | — |